Synopsis

Many solid renal neoplasms have characteristic features on imaging. Imaging biomarkers can be used to non-invasively identify histology of the most common subtypes of renal cell carcinoma and can be used to assess response to therapy. No one biomarker can accurately differentiate all renal masses, as some renal masses have features in common, necessitating attention to all images, phases, or sequences.